Oxygen therapy reduces ED

  • Sen V & al.
  • Aging Male
  • 23 Mar 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Hyperbaric oxygen therapy (HBOT) reduces erectile dysfunction (ED) but does not affect serum testosterone levels.

Why this matters

  • HBOT may be a good alternative or supportive treatment for patients with ED.

Study design

  • Researchers studied patients with ED who underwent 30 sessions of HBOT (n=43; mean age, 59.9±11.4 years), comparing pre- and posttreatment International Index of Erectile Function (IIEF) scores, serum total testosterone (TT), and free testosterone (FT).
  • Funding: None disclosed.

Key results

  • Patients had significantly higher posttreatment IIEF scores (mean score, 25.4±5.3 vs 20.6±5.1; P<.001>
  • Patients had no statistically significant differences in pre- and posttreatment serum TT (4.0±2.3 vs 4.1±2.0 ng/mL; P=.797) or FT (8.6±3.8 vs 8.9±3.5 pg/mL; P=.658).

Limitations

  • The study was single-center with a small sample size and no control group.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit